|
ILF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.437900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.991300E-04 |
| Normal-vs-Stage2 |
2.934000E-02 |
| Normal-vs-Stage3 |
2.365000E-01 |
| Normal-vs-Stage4 |
6.772400E-01 |
| Stage1-vs-Stage2 |
9.781400E-01 |
| Stage1-vs-Stage3 |
5.562600E-03 |
| Stage1-vs-Stage4 |
2.511600E-01 |
| Stage2-vs-Stage3 |
1.528320E-02 |
| Stage2-vs-Stage4 |
2.983000E-01 |
| Stage3-vs-Stage4 |
3.236600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.459600E-03 |
| Normal-vs-AfricanAmerican |
2.182400E-03 |
| Normal-vs-Asian |
8.240800E-01 |
| Caucasian-vs-AfricanAmerican |
4.528600E-01 |
| Caucasian-vs-Asian |
5.560000E-01 |
| AfricanAmerican-vs-Asian |
4.924600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.583900E-04 |
| Normal-vs-Female |
7.690400E-01 |
| Male-vs-Female |
1.124330E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.393560E-01 |
| Normal-vs-Extreme_Weight |
2.247800E-04 |
| Normal-vs-Obese |
1.865580E-01 |
| Normal-vs-Extreme_Obese |
1.411510E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.645240E-01 |
| Normal_Weight-vs-Obese |
7.818000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.398100E-02 |
| Extreme_Weight-vs-Obese |
6.170200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.058400E-01 |
| Obese-vs-Extreme_Obese |
5.349600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.791000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.684040E-02 |
| Normal-vs-Age(61-80Yrs) |
3.684000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.660130E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.366400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.750150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.455800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.876000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.870200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.493800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.821150E-04 |
| Normal-VS-Type2 PRCC |
5.344400E-01 |
| Normal-VS-KIRP CIMP |
9.970400E-01 |
| Normal-VS-Unclassified PRCC |
2.265900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.407900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.303820E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.125600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.919200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.894180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.054800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.799500E-03 |
| Normal-vs-N1 |
7.716100E-02 |
| Normal-vs-N2 |
6.671400E-01 |
| N0-vs-N1 |
5.385000E-04 |
| N0-vs-N2 |
7.782400E-01 |
| N1-vs-N2 |
2.534000E-01 |
|
|
